Making Informed Consent Safer in Psilocybin Services: What Experts Recommend
As psilocybin services and psychedelic-assisted therapy become more available, one question is becoming increasingly important: what does truly informed consent look like when a person is preparing for a psilocybin experience? A recent qualitative study in Neuroethics explored this question by interviewing people with substantial expertise in psilocybin services across clinical trial, underground, retreat, ceremonial, and other supervised settings.
A team of researchers including Christina Chwyl and Jason B. Luoma, PhD, from the Portland Institute for Psychedelic Science, examined expert recommendations for improving informed consent practices in psilocybin services. Their findings suggest that informed consent should not be treated as a one-time form, but as a living process grounded in trust, client empowerment, and ongoing communication.
Informed Consent Is More Than a Signature
In many healthcare settings, informed consent can become a document people sign before receiving care. In psilocybin services, the experts interviewed for this study argued that this is not enough. Because psilocybin can alter perception, increase emotional openness, and make people more vulnerable to influence, consent needs to be discussed carefully before, during, and after the experience.
Participants emphasized that consent should be relational. In other words, people need enough trust and safety with their provider to ask questions, express uncertainty, and change their mind. This is especially important because psychedelic experiences can be hard to predict, and people may not know in advance what they will need or want during the session.
Talking Honestly About Risks and Benefits
The study also highlighted the importance of discussing both potential benefits and potential risks in a balanced way. Psilocybin experiences may be meaningful, healing, or transformative for some people. They may also be confusing, disappointing, destabilizing, or emotionally difficult. Experts recommended that providers talk openly about physiological risks, psychological risks, social risks, and the possibility that a person may not experience improvement.
One especially important point was expectation management. The media often highlights dramatic stories of transformation, but psilocybin is not a guaranteed cure or “magic bullet.” The study found that people with very high hopes may be particularly vulnerable to disappointment if the experience is difficult or does not lead to the changes they expected. Experts recommended that providers clearly explain the full range of possible outcomes, including no improvement or worsening symptoms.
Touch, Boundaries, and Safety
A major theme in the study was the need for careful consent around touch. In psychedelic sessions, some providers may use supportive touch, such as holding a hand, to help someone feel grounded. However, because people are in an altered state and may be more vulnerable, experts emphasized that boundaries around touch must be discussed clearly before psilocybin is administered.
Participants recommended that providers explicitly state that sexual touch will never occur, define what therapeutic touch means, ask people where touch is and is not acceptable, and document these preferences. They also recommended practicing boundaries ahead of time, such as saying “yes,” saying “no,” asking for touch, or withdrawing consent.
The study also supported a conservative standard: a “no” given before a session should never become a “yes” during the session while the person is under the influence. This safeguard is especially important because altered states can affect decision-making, speech, and the ability to recognize or communicate discomfort.
Training Providers in Consent Skills
The authors also found that provider training should go beyond explaining rules. Experts recommended experiential training in boundary-setting, recognizing nonverbal cues, responding to ambivalence, communicating clearly, and centering client autonomy. This matters because some people may say “yes” even when they do not fully mean it, particularly if they have trauma histories, feel pressure to be a “good client,” or struggle to identify their own boundaries.
Moving the Field Forward
This study offers an important reminder: ethical psychedelic care depends not only on the substance used, but on the quality of the relationships, conversations, and safeguards surrounding it. As psilocybin services continue to expand, strong informed consent practices will be essential for making psychedelic-assisted therapy safer, more respectful, and more centered on client agency. The central message is simple but powerful: people deserve to understand what they are entering into, to have their boundaries respected, and to be able to change their mind.